Skip to main content
. 2012 Dec 26;7(12):e52398. doi: 10.1371/journal.pone.0052398

Figure 1. Engraftment and growth dynamics of MOPC-315.BM luc+ myeloma cells in vivo.

Figure 1

BALB/c wild type mice were injected with 1×105 MOPC-315.BM luc+ cells via the tail vein. Tumor growth and spread was regularly monitored by BLI. (A) BLI images of one representative mouse at indicated time points after MM injection from ventral (top) and dorsal (bottom) view. Additional emerging tumor foci over time are marked with black or white arrows. (B) Number of skeletal spots per mouse on days +11 (n = 51), 19 (n = 56) and 33 (n = 25) and (C) percentage of mice presenting signals from liver and spleen. (D) Quantification of single tumor foci over time as marked in (A): 1 and 2 = BM compartment of femur/tibia, 3 = spleen, 4 = BM compartment of shoulder. (E) Absolute signal quantification by whole body BLI from ventral and dorsal views. (F) Representative osteolytic lesion in the neck of femur 42 days after MM injection. Corticalis is marked as c which is destroyed (arrow) by MOPC-315.BM luc+ cells marked with T. Original magnification 40X, scale bar is 200 µm. Insert: original magnification 200X, scale bar is 100 µm.